Andere Sprachen BioMarin Pharmaceutical Inc.

Aktien

924801

US09061G1013

BMRN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
80,91 ^USD	-1,53 %		-8,71 %	-16,09 %

26.04.	BIOMARIN PHARMACEUTICAL INC. : Scotiabank klebt neutral	ZM
25.04.	BIOMARIN PHARMACEUTICAL INC. : Wells Fargo Securities gibt eine Kauf-Bewertung ab	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BioMarin Pharmaceutical Q1 Non-GAAP EPS, Revenue Increase -- Shares Down After Hours	24.04.
BioMarin: Q1 Earnings Snapshot	24.04.
(BMRN) BIOMARIN PHARMACEUTICAL Forecasts Fiscal Year 2024 EPS Range $2.75 - $2.95	24.04.
Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Posts Q1 Revenue $648.8M	24.04.
Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Posts Q1 EPS $0.71	24.04.
BioMarin Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24.04.
BioMarin Reports Record Financial Results for the First Quarter 2024	24.04.
BioMarin Pharmaceutical : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K	23.04.
BioMarin Pharmaceutical Investors to Focus Q1 on Strategic Review, Cost-Cutting Measures, UBS Says	22.04.
Biomarin Pharmaceutical Insider Sold Shares Worth $3,645,000, According to a Recent SEC Filing	15.04.
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET	10.04.
Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing	01.04.
New Data to be presented for BioMarin's VOXZOGO in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting	13.03.
BioMarin Pharmaceutical Says Voxzogo Leads to Height Gains in Children With Achondroplasia	12.03.
L'ETF della settimana: scommettere sull'inversione di tendenza delle biotech	09.03.
ETF van de week: inzetten op de ommekeer in de biotech	08.03.
ETF de la semaine : miser sur le retournement des Biotechs	08.03.
Biomarin Pharmaceutical Insider Sold Shares Worth $348,280, According to a Recent SEC Filing	07.03.
BioMarin Pharmaceutical Appoints Cristin Hubbard as Chief Commercial Officer	07.03.
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer	07.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BioMarin Pharmaceutical Inc.

Aktien

924801

US09061G1013

BMRN

Andere Sprachen

Filter